Orofacial Manifestations and Temporomandibular Disorders of Systemic Scleroderma: An Observational Study

被引:58
|
作者
Crincoli, Vito [1 ]
Fatone, Laura [1 ]
Fanelli, Margherita [2 ]
Rotolo, Rossana Patricia [1 ]
Chiala, Angela [3 ]
Favia, Gianfranco [1 ]
Lapadula, Giovanni [3 ]
机构
[1] Aldo Moro Univ Bari, Interdisciplinary Dept Med, Complex Operating Unit Odontostomatol, Piazza Giulio Cesare 11, I-70124 Bari, Italy
[2] Aldo Moro Univ Bari, Interdisciplinary Dept Med, Complex Operating Unit Nucl Med Med Stat, Piazza Giulio Cesare 11, I-70124 Bari, Italy
[3] Aldo Moro Univ Bari, Interdisciplinary Dept Med, Complex Operating Unit Rheumatol, Piazza Giulio Cesare 11, I-70124 Bari, Italy
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2016年 / 17卷 / 07期
关键词
scleroderma; oral manifestation; temporomandibular disorders; LOCALIZED SCLERODERMA; CONSECUTIVE PATIENTS; ORAL MANIFESTATIONS; SCLEROSIS PATIENTS; JOINT; INVOLVEMENT; ARTHRITIS;
D O I
10.3390/ijms17071189
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Scleroderma is a disorder involving oral and facial tissues, with skin hardening, thin lips, deep wrinkles, xerostomia, tongue rigidity, and microstomia. The aim of this study was to investigate the prevalence of oral manifestations and temporomandibular disorders (TMD) in Systemic Sclerosis (SSc) patients compared with healthy people. Eighty patients (6 men, 74 women) fulfilling ACR/EULAR SSc Criteria were enrolled. A randomly selected group of 80 patients, matched by sex and age served as control group. The examination for TMD signs and symptoms was based on the standardized Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) through a questionnaire and clinical examination. SSc patients complained more frequently (78.8%) of oral symptoms (Xerostomia, dysgeusia, dysphagia and stomatodynia) than controls (28.7%) ((2) = 40.23 p = 0.001). TMD symptoms (muscle pain on chewing, difficulty in mouth opening, headaches) were complained by 92.5% of SSc patients and by 76.2% of controls ((2) = 8.012 p = 0.005). At the clinical examination, 85% of SSc patients showed restricted opening versus 20.0% of controls ((2) = 67.77 p = 0.001), 81.2% of SSc showed reduced right lateral excursion versus 50% of controls ((2) = 17.316 p = 0.001); 73.8% of SSc showed limited left lateral excursion versus 53.8% of controls ((2) = 6.924 p = 0.009); and 73.8% of SSc had narrow protrusion versus 56.2% of controls ((2) = 5.385 p = 0.02).
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Temporomandibular Disorders in Burning Mouth Syndrome Patients: An Observational Study
    Corsalini, Massimo
    Di Venere, Daniela
    Pettini, Francesco
    Lauritano, Dorina
    Petruzzi, Massimo
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (12): : 1784 - 1789
  • [32] Systemic scleroderma - prognosis determined by internal manifestations
    Mittag, M
    Haustein, UF
    HAUTARZT, 1998, 49 (07): : 545 - 551
  • [33] Gastrointestinal Manifestations of Systemic Lupus Erythematosus and Scleroderma
    Daruwala, Cherag
    Mercogliano, Giancarlo
    Harder, Thomas P.
    CLINICAL MEDICINE INSIGHTS-GASTROENTEROLOGY, 2009, 2 : 7 - 12
  • [34] THE RADIOLOGICAL MANIFESTATIONS OF DIFFUSE SYSTEMIC SCLEROSIS (SCLERODERMA)
    HARPER, RAK
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1954, 46 (07): : 512 - 522
  • [35] CARDIAC AND RENAL MANIFESTATIONS IN PROGRESSIVE SYSTEMIC SCLERODERMA
    ROTTENBERG, EN
    SLOCUMB, CH
    EDWARDS, JE
    PROCEEDINGS OF THE STAFF MEETINGS OF THE MAYO CLINIC, 1959, 34 (03): : 77 - A82
  • [36] RHEUMATIC MANIFESTATIONS OF PROGRESSIVE SYSTEMIC SCLEROSIS (SCLERODERMA)
    RODNAN, GP
    MEDSGER, TA
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1968, (57) : 81 - &
  • [37] THE CARDIOVASCULAR MANIFESTATIONS OF SYSTEMIC-SCLEROSIS (SCLERODERMA)
    FOLLANSBEE, WP
    CURRENT PROBLEMS IN CARDIOLOGY, 1986, 11 (05) : 245 - 290
  • [38] The spectrum of orofacial manifestations in systemic sclerosis: a challenging management
    Jung, S.
    Martin, T.
    Schmittbuhl, M.
    Huck, O.
    ORAL DISEASES, 2017, 23 (04) : 424 - 439
  • [39] Orofacial function and temporomandibular disorders in Parkinson's Disease: a case-controlled study
    Baram, Sara
    Thomsen, Carsten Eckhart
    Ozhayat, Esben Boeskov
    Karlsborg, Merete
    Bakke, Merete
    BMC ORAL HEALTH, 2023, 23 (01)
  • [40] Headache impact in temporomandibular disorders (TMD) and orofacial pain patients: MIDAS Study.
    Mitrirattanakul, S
    Merrill, R
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A130 - A130